Back

KKR to sell 10% Nordic Bioscience stake to founder Claus Christiansen

Verifying
  • KKR agreed to sell its Nordic Bioscience minority stake to founder Claus Christiansen.
  • 10% was KKR’s stake, acquired through its 2021 Health Care Strategic Growth investment.
  • Håkan Björklund will leave the board, while Christiansen becomes Chair.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.